New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
08:32 EDTSQNMSequenom price target raised to $5 from $4 at Wedbush
Wedbush raised its price target on Sequenom after Quest agreed to begin using the company's MaterniT21 Plus test for fetal chromosomal abnormalities. The firm notes that the deal displaces one of Sequenom's competitors, and says that it will allow Sequenom to regain clear U.S. leadership of the category while improving its path to profitability. The firm keeps an Outperform rating on Sequnom.
News For SQNM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
15:46 EDTSQNMPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 22, 2015
07:04 EDTSQNMSequenom and Cypher Genomics sign prenatal test development agreement
Subscribe for More Information
January 20, 2015
13:45 EDTSQNMIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use